Côte d'Ivoire vs Ghana: Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Ghana
100.0%
in 2024
Côte d'Ivoire rank
1st
Ghana rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Ghana
How they compare
Côte d'Ivoire currently reports 100.0% against 100.0% in Ghana, a difference of 0.0%.
The two have swapped places 6 times across 16 shared years of data; in 2005 it was Ghana ahead.
Côte d'Ivoire ranks 1st and Ghana ranks 1st of 180 countries.
Ghana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.9% | 6.7% | 4.8% | Ghana |
| 2010s | 60.3% | 64.7% | 4.4% | Ghana |
| 2020s | 98.4% | 98.6% | 0.2% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Ghana?
- Côte d'Ivoire, at 100.0% against 100.0% in Ghana as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Ghana?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Ghana?
- 16 years are reported by both, from 2005 to 2024.
- How do Côte d'Ivoire and Ghana rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Ghana ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.